Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases

BACKGROUND: Circulating cell‐free tumor DNA (ctDNA)‐based mutation profiling, if sufficiently sensitive and comprehensive, can efficiently identify genomic targets in advanced lung adenocarcinoma. Therefore, the authors investigated the accuracy and clinical utility of a commercially available digit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mack, Philip C., Banks, Kimberly C., Espenschied, Carin R., Burich, Rebekah A., Zill, Oliver A., Lee, Christine E., Riess, Jonathan W., Mortimer, Stefanie A., Talasaz, AmirAli, Lanman, Richard B., Gandara, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383626/
https://www.ncbi.nlm.nih.gov/pubmed/32365229
http://dx.doi.org/10.1002/cncr.32876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383626/
https://www.ncbi.nlm.nih.gov/pubmed/32365229
http://dx.doi.org/10.1002/cncr.32876

Ejemplares similares